04:37 PM EDT, 03/20/2025 (MT Newswires) -- TELA Bio ( TELA ) reported a Q4 net loss Thursday of $0.23 per diluted share, compared to a loss of $0.53 a year earlier.

One analyst polled by FactSet expected a loss of $0.24.

Revenue for the quarter ended Dec. 31 was $17.6 million, up from $17 million a year earlier.

Analysts polled by FactSet expected $23.2 million.

For Q1, the company has a revenue outlook of $17 million to $18 million. Four analysts expect $21 million.

The company expects full-year 2025 revenue between $85 million to $88 million. Analysts expect $93.8 million.

Shares fell 24% in recent after-hours activity.